Instem plc Notice of Results (3621T)

TIDMINS

RNS Number : 3621T

Instem plc

20 March 2019

Instem plc

("Instem" or the "Company")

Notice of Results

Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, will announce full year results for the year ended 31 December 2018 on Monday 1 April 2019.

Analyst Presentation

Management will be hosting a presentation on the day of the results at 10.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD. Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.

Investor Presentation

The Company will also be hosting a presentation for investors in London on Tuesday 2 April 2019. Phil Reason, CEO of the Company will present financial and operational results for the year ended 31 December 2018, as well as an overview of the Company and its plans for the future.

The event is open to all investors and will be held from 16.30 for a 16.45 start at a venue in the City. To register for the event, please email instem@walbrookpr.com or call the Walbrook PR team, below.

For further information, please contact:

 
 Instem plc                       +44 (0) 1785 825 600 
 Phil Reason, CEO 
 Nigel Goldsmith, CFO 
 
 N+1 Singer (Nominated Adviser 
  & Broker)                       +44 (0) 20 7496 3000 
 Richard Lindley 
  Rachel Hayes 
 
 Walbrook Financial PR            +44 (0) 20 7933 8780 
 Paul Cornelius                   instem@walbrookpr.com 
 Nick Rome 
  Sam Allen

About Instem

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.

Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.

To learn more about Instem solutions and its mission, please visit instem.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORFMGMFNLVGLZM

(END) Dow Jones Newswires

March 20, 2019 03:02 ET (07:02 GMT)

Instem (LSE:INS)
Historical Stock Chart
From Jul 2024 to Aug 2024